Pfizer's and Moderna's formulas have been the go-to on pharmacy shelves, but Novavax remains an important option.

Health Canada said Thursday it has authorized Novavax's updated COVID-19 vaccine for those aged 12 years and up.

Health Canada has authorized Novavax's updated COVID-19 vaccine that protects against currently circulating variants of the ...

The Food and Drug Administration (FDA) has authorized the emergency use of the Novavax COVID-19 Vaccine, Adjuvanted.

Health Canada has approved an updated Novavax COVID-19 vaccine to protect against the variants of the virus currently ...

However, with COVID-19 stubbornly sticking around, investors should focus on an obscure, up-and-coming COVID-19 vaccine maker called Novavax. Novavax (NVAX) is a biotech company that develops ...

As of 11:21 AM EDT. Market Open. Though Novavax is behind in the COVID-19 vaccine race, a blockbuster deal with Sanofi and a differentiated product means the stock offers the best reward prospects ...

They are Pfizer’s Comirnaty, which is also an mRNA vaccine, as well as Novavax’s protein-based vaccine. Like Moderna’s vaccine, the Pfizer vaccine under review targets the KP.2 strain.

Those vaccines are for people 6 months and older. A more traditional protein vaccine from Novavax is also available, but it targets JN.1, a variant that is still circulating but less prominently than ...

They are Pfizer's Comirnaty, which is also an mRNA vaccine, as well as Novavax's protein-based vaccine. "Health Canada anticipates issuing a decision regarding the Novavax and Pfizer COVID-19 ...